Barrington Research Forecasts USPH FY2024 Earnings

U.S. Physical Therapy, Inc. (NYSE:USPH) – Analysts at Barrington Research lifted their FY2024 earnings estimates for shares of U.S. Physical Therapy in a research note issued on Thursday, November 7th. Barrington Research analyst M. Petusky now forecasts that the company will post earnings per share of $2.49 for the year, up from their prior forecast of $2.20. Barrington Research currently has a “Outperform” rating and a $108.00 target price on the stock. The consensus estimate for U.S. Physical Therapy’s current full-year earnings is $2.67 per share. Barrington Research also issued estimates for U.S. Physical Therapy’s Q3 2025 earnings at $0.62 EPS, FY2025 earnings at $2.52 EPS and FY2026 earnings at $2.88 EPS.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings results on Tuesday, August 13th. The company reported $0.73 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.82 by ($0.09). The company had revenue of $167.19 million during the quarter, compared to analysts’ expectations of $163.34 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The business’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.76 EPS.

Other equities analysts also recently issued reports about the stock. StockNews.com upgraded shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Wednesday, August 21st. Bank of America restated a “neutral” rating and set a $90.00 target price (down from $114.00) on shares of U.S. Physical Therapy in a report on Monday, October 7th.

U.S. Physical Therapy Stock Performance

Shares of USPH opened at $94.54 on Monday. The company has a 50-day simple moving average of $83.80 and a 200-day simple moving average of $91.31. The company has a quick ratio of 1.88, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. The company has a market capitalization of $1.43 billion, a PE ratio of 100.57, a P/E/G ratio of 4.40 and a beta of 1.38. U.S. Physical Therapy has a 52-week low of $76.18 and a 52-week high of $113.63.

U.S. Physical Therapy Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Friday, November 15th will be issued a dividend of $0.44 per share. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.86%. U.S. Physical Therapy’s dividend payout ratio (DPR) is presently 187.23%.

Insider Transactions at U.S. Physical Therapy

In other news, COO Graham D. Reeve sold 1,724 shares of U.S. Physical Therapy stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total transaction of $142,230.00. Following the completion of the sale, the chief operating officer now directly owns 7,038 shares in the company, valued at $580,635. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In related news, COO Graham D. Reeve sold 1,724 shares of the business’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total value of $142,230.00. Following the completion of the sale, the chief operating officer now directly owns 7,038 shares in the company, valued at approximately $580,635. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Kathleen A. Gilmartin bought 2,000 shares of the stock in a transaction that occurred on Tuesday, September 3rd. The stock was bought at an average price of $86.09 per share, with a total value of $172,180.00. Following the completion of the acquisition, the director now owns 18,904 shares of the company’s stock, valued at $1,627,445.36. This trade represents a 0.00 % increase in their position. The disclosure for this purchase can be found here. Insiders own 1.70% of the company’s stock.

Institutional Investors Weigh In On U.S. Physical Therapy

A number of institutional investors have recently bought and sold shares of USPH. Canada Pension Plan Investment Board purchased a new stake in U.S. Physical Therapy in the second quarter valued at approximately $28,000. Innealta Capital LLC purchased a new stake in U.S. Physical Therapy in the second quarter valued at approximately $30,000. Quest Partners LLC grew its holdings in U.S. Physical Therapy by 2,808.3% in the second quarter. Quest Partners LLC now owns 349 shares of the company’s stock valued at $32,000 after purchasing an additional 337 shares during the period. Quarry LP grew its holdings in U.S. Physical Therapy by 1,291.9% in the second quarter. Quarry LP now owns 515 shares of the company’s stock valued at $48,000 after purchasing an additional 478 shares during the period. Finally, Ridgewood Investments LLC purchased a new stake in U.S. Physical Therapy in the second quarter valued at approximately $51,000.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.